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2A The Problem: Vermonters are still smoking.
▪ According to the 2019 Vermont Tobacco Pages update:1
▪ 17% of  Vermont adults are smokers (vs. 14% of  adults nationwide)
▪ 20th: Vermont state rank in adult smoking prevalence nationwide2
▪ 8/14 counties have ≥20% prevalence of  adult smoking
▪ Areas served by Newport and Springfield hospitals have the greatest prevalence in the 
state (24% and 27%, respectively).
▪ These data suggest opportunity for further intervention, both statewide and 
locally, and within healthcare institutions as well.
1. 2017 Vermont Tobacco Pages, Vermont Department of Health.
2. Campaign for Tobacco-Free Kids, “The Toll of Tobacco in the US,” (2019), available at https://www.tobaccofreekids.org/problem/toll-us
2B The Problem, part 2: low awareness of  
genitourinary effects of  smoking
▪ Smoking is the #1 risk factor in developing urothelial carcinoma of  the 
bladder. Quitting reduces that risk:3,4
▪ Current smokers: Hazard ratio 3.89 in men, 4.65 in women
▪ Former smokers: Hazard ratio 2.07 in men, 2.89 in women
▪ Heavier smoking also correlates with more aggressive bladder cancer.5
▪ Erectile dysfunction and CVD share many risk factors, including smoking.
▪ Cessation produced significant improvement in ED within a month in one prospective 
cohort study.6
▪ Smoking concurrence with prostate cancer has been linked with greater risk 
of  mortality, metastasis, and recurrence.7,8
▪ Even among urology patients, there is generally low awareness of  smoking-
related genitourinary disease9 - an opportunity to educated and incentivize 
patients to quit.
3. Freedman et al., "Association between smoking and risk of bladder cancer among men and women." JAMA 306, no. 7 (2011): 737-745.
4. Cumberbatch et al., "The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks." European urology 70, no. 3 (2016): 458-466.
5. Pietzak et al. "Heavy cigarette smoking and aggressive bladder cancer at initial presentation." Urology 86, no. 5 (2015): 968-973.
6. Guay et al., "Cessation of smoking rapidly decreases erectile dysfunction." Endocrine Practice 4, no. 1 (1998): 23-26.
7. Islami et al., "A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies." European urology 66, no. 6 (2014): 1054-1064.
8. Foerster et al.,"Association of smoking status with recurrence, metastasis, and mortality among patients with localized prostate cancer undergoing prostatectomy or radiotherapy: a systematic review and meta-analysis." JAMA oncology 4, no. 7 (2018): 953-961.
9. Bjurlin et al., "Ethnicity and smoking status are associated with awareness of smoking related genitourinary diseases." The Journal of urology 188, no. 3 (2012): 724-728.
3A Public Health Costs of  Tobacco Use
▪ According to the Vermont Tobacco Control State Plan, 2015-2020:10
▪ $348 million per year: amount Vermonters spend on tobacco-related healthcare
▪ 1000: tobacco-related deaths per year
**Unfortunately, no public data on the cost of  genitourinary disease to Vermonters could be 
found, and calls placed to the Vermont Department of  Health were not returned.
10. Vermont Department of Health, Vermont Tobacco Control State Plan, 2015-2020: Collaborating to Reduce Tobacco Use for a Healthier Vermont
3B. Public Health Burden of  Genitourinary 
Disease
Prostate and bladder cancer are among the top 5 cancers in incidence and mortality 
affecting Vermont men:11
Incidence Mortality
11. Vermont Department of Health, 2016-2020 Vermont Cancer Plan: A Framework for Action: 5
4A Community Perspective on Smoking and 
Resources for Quitting12
▪ Viki Delmas, Vermont Quit Partner (CVMC):
▪ COVID-19 has simultaneously created greater incentive to quit and greater levels of  
stress leading to more relapses.
▪ With more people at home, there’s more flexibility with getting them resources they 
need.
▪ Nancy Wagner, RDN, CDC, CHC, TTS (CVMC):
▪ Resources:
▪ 802Quits provides 8 weeks of  free nicotine replacement per year
▪ The Blueprint Grant allowed for unlimited group and one-on-one counseling sessions that would normally 
be limited by insurance coverage -> this grant is disappearing soon.
▪ Access to resources is NOT the issue in lowering smoking rates in VT. It’s patient 
motivation. 90% is the habit; 10% is the nicotine addiction. 
▪ Anything to drive that motivation would be beneficial, including education about 
genitourinary effects.
12. Remarks above are paraphrased from interviews conducted via telephone and are not direct quotations.
4B Community Perspective on Smoking-Related 
Genitourinary Disease Incentivization to Quit13
• Brian Rodriguez, MD (CVMC Family Medicine):
• Using prostate and bladder cancer to incentivize quitting smoking is a good idea. Lots of  
patients don’t realize the connection between the two.
• The same is true for ED. It’s a blood flow issue, and smoking makes it worse. I often use 
that to try to get male patients to quit.
13. Remarks above are paraphrased from an in-person discussion and are not direct quotations.
5. Intervention & Methodology
▪ Intervention: patient education materials
▪ Medium: poster
▪ Content: information regarding genitourinary effects of  smoking in men, with an 
entertaining, traditionally male-centric theme
▪ Rationale: an eye-catching poster with a theme catering towards one sex may be more effective 
than a gender-neutral poster aimed at both sexes
▪ Location: to be displayed in patient bathrooms in healthcare practices
▪ Rationale: discreet location for relaying information about intimate/private body system; patient 
bathrooms tend to be minimally adorned with decorations/other materials, allowing for 
maximum impact and minimum distraction
▪ Duration: to be displayed at the discretion of  practice manager and medical director
6 Results & Response
▪ Informal pilot survey: prior to the creation of  the final draft of  the poster 
and its display, a small number of  actively smoking male patients (n=4) were 
offered brief  counseling on genitourinary effects of  smoking. 
▪ All were receptive to the information; two expressed no prior knowledge of  
these effects. 
7 Effectiveness & Limitations
▪ Effectiveness:
▪ Patients and providers appeared to be receptive and appreciative of  the poster’s design
▪ One patient expressed appreciation that the poster had “personality” which is “rare in 
this kind of  [educational] stuff ”
▪ The poster immediately attracts attention in the bathroom, especially in the absence of  
other distracting materials or decorations
▪ Limitations:
▪ Information only reaches patients who use the bathroom
▪ Passive form of  education; direct communication from physician would likely have more 
impact
▪ Still requires significant action on the part of  the patient (e.g. “Ask your doctor…”)
▪ No mechanism in place for evaluating efficacy
8 Recommendations for Future Projects
▪ In general, continue to make materials targeted for specific populations,
with themes that appeal/speak to those groups
▪ Design formal survey that evaluates current patient knowledge of  
genitourinary effects of  smoking. Repeat survey in 12 months to evaluate 
penetrative power of  educational poster
▪ If  significant improvement in patient knowledge: identify another demographic for 
targeted smoking cessation education/therapy and repeat process
▪ If  no significant improvement: re-evaluate poster design, location, and content
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     HAVE    YOU    TAKEN    A  
BELOW 
BELT ? 











~~~~~~~~~~~~~~as well as~~~~~~~~~~~~~~~ 
HIGHER MORTALITY, RECURRENCE, & SPREAD  OF 
THE MORE YOU SMOKE, 









READY  TO  IMPROVE  YOUR PHYSICAL & SEXUAL HEALTH? 
ASK YOUR DOCTOR 
ABOUT QUITTING TODAY, OR CALL 1-800-QUIT-NOW 
AND GET BACK IN THE RING. 
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